המדריך לשימוש בנוגדי הקרישה החדשים בפרפור פוזדורים

23 / 24

23
ספרות:
1. H. Heidbuchel etal. Europace (2013) 15, 625-651
2. A. John Cammetal. European Heart Jairnal (2012) 33, 2719-2747
3. 2014 AHA/ACC/HRS guidelines for the management of patients with atrial fibrillation. Circulation 2014
published online 28.3.2014
4. 2012 focused update of the ESC guidelines for the management of patients with atrial fibrillation.
Europace. 2012 Oct;14(10):1385-413.
5. Giogliano RP et al. Edoxaban versus warfarin in patients with atrial fibrillation. N Engl J Med. 2013 Nov
28;369(22):2093-104.
6. Connolly SJ et al. Dabigatran versus warfarin in patients with atrial fibrillation. N Engl J Med. 2009 Sep
17;361(12):1139-51
7. Patel MR et al. Rivaroxaban versus warfarin in nonvalvular atrial fibrillation. N Engl J Med. 2011 Sep
8;365(10):883-91
8. Granger CB et al. Apixaban versus warfarin in patients with atrial fibrillation. N Engl J Med. 2011 Sep
15;365(11):981-92
9. De Caterina R, Camm AJ. What is “valvular” atrial fibrillation? A reappraisal. European Heart Journal
(2014) 35, 3328–3335
המסמך הודפס בחסות: